Premature menopause or early menopause and risk of ischemic stroke

Menopause

Volumn 19, Issue 3, 2012, Pages 272-277

  Rocca, Walter A ^a,b   Grossardt, Brandon R ^b   Miller, Virginia M ^a   Shuster, Lynne T ^a   Brown Jr , Robert D ^b  

^a Information Technology   (United States)

^b Department of Health Sciences Research ^*  (United States)

Author keywords

Early menopause; Estrogen; Ischemic stroke; Oophorectomy; Risk factors

Indexed keywords

ESTROGEN;

ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; EARLY MENOPAUSE; HORMONAL THERAPY; HUMAN; OBSERVATIONAL STUDY; OVARIECTOMY; OVARY; RISK BENEFIT ANALYSIS; RISK FACTOR;

COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE, PREMATURE; OVARIECTOMY; RISK; STROKE;

EID: 84857538401     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31822a9937     Document Type: Article

References (55)

1. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003;289:2673-2684. (Pubitemid 37430138)
2. Bath PM, Gray LJ. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005;330:342.
3. Bushnell CD. Oestrogen and stroke in women: assessment of risk. Lancet Neurol 2005;4:743-751. (Pubitemid 41457290)
4. Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006;113:2425-2434. (Pubitemid 43948050)
5. Magliano DJ, Rogers SL, Abramson MJ, Tonkin AM. Hormone therapy and cardiovascular disease: a systematic review and meta-analysis. BJOG 2006;113:5-14.
6. Grodstein F, Manson JE, Stampfer MJ, Rexrode K. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med 2008;168:861-866. (Pubitemid 351620088)
7. Sare GM, Gray LJ, Bath PM. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a metaanalysis. Eur Heart J 2008;29:2031-2041.
8. Lee JS, Yaffe K, Lui LY, et al. Prospective study of endogenous circulating estradiol and risk of stroke in older women. Arch Neurol 2010;67: 195-201.
9. The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:242-255.
10. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-619. (Pubitemid 34175253)
11. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006;166:357-365. (Pubitemid 43244325)
12. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-2602. (Pubitemid 46961004)
13. Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med 2007;356:2639-2641. (Pubitemid 46964429)
14. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477. (Pubitemid 46556472)
15. Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15-23.
16. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161-166.
17. The North American Menopause Society. Menopause Practice: A Clinician's Guide, 4th ed. Cleveland, OH: The North American Menopause Society, 2010.
18. Cui R, Iso H, Toyoshima H, et al. Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC Study. J Epidemiol 2006;16:177-184. (Pubitemid 44574682)
19. de Leciñana MA, Egido JA, Fernández C, et al. Risk of ischemic stroke and lifetime estrogen exposure. Neurology 2007;68:33-38. (Pubitemid 46058548)
20. Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol 2009;113:1027-1037.
21. Parker WH, Jacoby V, Shoupe D, Rocca W. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond Engl) 2009;5:565-576.
22. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: the Framingham Heart Study. Stroke 2009;40:1044-1049.
23. Baba Y, Ishikawa S, Amagi Y, Kayaba K, Gotoh T, Kajii E. Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010;17:506-510.
24. Ingelsson E, Lundholm C, Johansson AL, Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J 2011;32:745-750.
25. Jacoby VL, Grady D, Wactawski-Wende J, et al. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011;171:760-768.
26. Parker WH, Manson JE. Oophorectomy and cardiovascular mortality: is there a link? Menopause 2009;16:1-2.
27. Rocca WA, Shuster LT, Grossardt BR, et al. Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) 2009;5:39-48.
28. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-1990. Med J Aust 1993;158:85-89. (Pubitemid 23045197)
29. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 2005;58:688-697. (Pubitemid 41552544)
30. Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril 2004;82:391-397. (Pubitemid 39092040)
31. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999;30:2513-2516.
32. Woo D, Gebel J, Miller R, et al. Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke 1999;30: 2517-2522.
33. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811. (Pubitemid 29266405)
34. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-1587. (Pubitemid 40807497)
35. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-1304.
36. LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305: 1305-1314.
37. Jungheim ES, Colditz GA. Short-term use of unopposed estrogen: a balance of inferred risks and benefits. JAMA 2011;305:1354-1355.
38. Duckles SP, Krause DN, Stirone C, Procaccio V. Estrogen and mitochondria: a new paradigm for vascular protection? Mol Interv 2006;6: 26-35. (Pubitemid 43327520)
39. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008;60:210-241. (Pubitemid 351962010)
40. Suzuki S, Brown CM, Wise PM. Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol 2009;30:201-211.
41. Chambliss KL, Wu Q, Oltmann S, et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 2010;120:2319-2330.
42. Mendelsohn ME, Karas RH. Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest 2010;120:2277-2279.
43. Register T, Sophonsritsuk A, Appt SE. Estrogen inhibits carotid artery inflammation in early but not late menopause in cynomolgus monkeys [Abstract S-2] Menopause 2010;17:1216.
44. Zhang B, Subramanian S, Dziennis S, et al. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J Immunol 2010;184:4087-4094.
45. Bushnell CD, Hurn P, Colton C, et al. Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke 2006;37: 2387-2399. (Pubitemid 44337191)
46. Raval AP, Bhatt A, Saul I. Chronic nicotine exposure inhibits 17A-estradiolY mediated protection of the hippocampal CA1 region against cerebral ischemia in female rats. Neurosci Lett 2009;458:65-69.
47. Shuster LT, Grossardt BR, Gostout BS, Rocca WA. Prophylactic bilateral oophorectomy jeopardizes long-term health. Sex Reprod Menopause 2010;8:S1, S3-S5.
48. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010;376:911-921.
49. Vujovic S, Brincat M, Erel T, et al. EMAS position statement: managing women with premature ovarian failure. Maturitas 2010;67:91-93.
50. Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042-1050. (Pubitemid 40458772)
51. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140:184-188.
52. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53. (Pubitemid 38040534)
53. Chubaty A, Shandro MT, Schuurmans N, Yuksel N. Practice patterns with hormone therapy after surgical menopause. Maturitas 2011;69:69-73.
54. Parente L, Uyehara C, Larsen W, Whitcomb B, Farley J. Long-term impact of the Women's Health Initiative on HRT. Arch Gynecol Obstet 2008;277:219-224. (Pubitemid 351239593)
55. Silverman BG, Kokia ES. Use of hormone replacement therapy, 1998-2007: sustained impact of the Women's Health Initiative findings. Ann Pharmacother 2009;43:251-258.